Enspryng 50242-0007
Generic: Satralizumab
Product NDC
50242-0007- Manufacturer
- Genentech, Inc.
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- August 14, 2020
- Listing Expires
- December 31, 2026
- Application
- BLA761149
Need to source Enspryng? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Satralizumab | 120 mg/mL |
Packaging Options(2)
1 SYRINGE, PLASTIC in 1 CARTON (50242-007-01) / 1 mL in 1 SYRINGE, PLASTIC
1 SYRINGE, PLASTIC in 1 CARTON (50242-007-86) / 1 mL in 1 SYRINGE, PLASTIC